Warp Sciences, founded by a former OpenAI executive, secures $215 million to launch AI‑powered drug research labs. The company will use AI models trained on lab data to guide robotic synthesis of molecular variants, integrating chemists and automation for faster drug candidate development.
Opening Kapyn…